List of works by Matthew D Snape

'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents

scientific article published on 22 October 2020

A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children.

scientific article

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.

scientific article published on May 2011

A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccine

scientific article

A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?

scientific article published on August 2013

A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.

scientific article

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.

scientific article

A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella

scientific article published on 22 March 2018

Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later.

scientific article

Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease

scientific article published in April 2013

African tick bite fever

scientific article published on 01 November 2006

An increase in accident and emergency presentations for adverse events following immunisation after introduction of the group B meningococcal vaccine: an observational study

scientific article published on 09 August 2017

Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children

article

Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation.

scientific article published on 2 January 2018

Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults

scientific article

Antibody-Dependent Natural Killer Cell Activation after Ebola Vaccination

scientific article published on 10 December 2019

Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans

scientific article published on 20 October 2009

Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire Study

scientific article published on 01 September 2019

Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionals

scientific article published on 15 June 2016

Attitudes towards vaccination against group B streptococcus in pregnancy.

scientific article

Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: a follow-on study to a randomized clinical trial.

scientific article

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine

scientific article published in May 2012

COVID-19 in children and young people

scientific article published on 21 September 2020

Common Genetic Variations Associated with the Persistence of Immunity following Childhood Immunization

scientific article published on 01 June 2019

Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial

scientific article published on 18 February 2015

Control of invasive meningococcal disease: is it achievable?

scientific article published on 29 June 2015

Corrigendum to “Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial” [Vacci

scientific article published on 05 May 2017

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine

scientific article published on February 2009

Determinants of Influenza and Pertussis Vaccination Uptake in Pregnancy

scientific article published on 01 June 2019

Differences in Immunization Site Pain in Toddlers Vaccinated with Either the 10- or the 13-Valent Pneumococcal Conjugate Vaccine.

scientific article published on 10 January 2018

Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule.

scientific article

Ebola virus glycoprotein stimulates IL-18 dependent natural killer cell responses

scientific article published on 21 April 2020

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

scientific article

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

scientific article

Emerging clinical experience with vaccines against group B meningococcal disease.

scientific article published on August 2017

Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines--exploratory analyses within a randomised controlled trial

scientific article

Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine

scientific article

Factors affecting the causality assessment of adverse events following immunisation in paediatric clinical trials: An online survey

scientific article published on 6 November 2015

Factors influencing women's attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: an online survey

scientific article published on 20 April 2016

Fine with five? Shorter antibiotic courses for childhood meningitis

scientific article published on 01 May 2011

First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults

scientific article published on 24 July 2019

Future of flu vaccines. Expediting clinical trials in a pandemic

scientific article published in the British Medical Journal

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine

scientific article published on 01 November 2020

Genetic material should be routinely collected in clinical vaccine trials--high consent rates can be achieved across all age groups

scientific article

Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement

scientific article published on 24 June 2020

H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study

scientific article

High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine

scientific article

Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults

scientific article published on 15 September 2009

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results

scientific article published on 13 June 2019

Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year.

scientific article published on March 2017

Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule

scientific article published on 16 August 2013

Immunisation of adolescents in the UK.

scientific article

Immunisation of the immunocompromised child.

scientific article published on 24 May 2016

Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants

scientific article published on 29 April 2020

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants

scientific article published on March 2009

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial

scientific article published on December 2010

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

scientific article published on February 2012

Immunogenicity of 2 Investigational Serogroup B Meningococcal Vaccines in the First Year of Life

scientific article published on 01 November 2010

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

scientific article published on January 2008

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial

scientific article

Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled tria

scientific article published on 08 January 2015

Interventions for increasing the uptake of immunisation in healthcare workers

scientific article

Interventions for increasing the uptake of immunisation in healthcare workers

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine

scientific article published on February 2005

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.

scientific article published on 13 July 2013

Lymphocyte subpopulations in premature infants: an observational study

scientific article published on 13 April 2016

Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.

scientific article published on 28 October 2011

Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13.

scientific article published on 6 April 2017

Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function

scientific article published on 01 August 2018

Meningococcal Vaccines

article from 2017

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy

scientific article published on 21 February 2015

Meningococcal meningitis presenting postinfant group B meningococcal immunisation

scientific article published on 05 December 2018

Meningococcal polysaccharide-protein conjugate vaccines.

scientific article

Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

scientific article

Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination.

scientific article

Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK c

scientific article published on October 2010

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol

scientific article published on 28 June 2019

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action.

scientific article

Persistence of Antibody Response Following a Booster Dose of Hib-MenC-TT Glycoconjugate Vaccine to Five Years

scientific article published on 01 October 2012

Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age.

scientific article

Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate Vaccine

article

Persistence of Serum Bactericidal Antibody One Year After a Booster Dose of Either a Glycoconjugate or a Plain Polysaccharide Vaccine Against Serogroup C Neisseria meningitidis Given to Adolescents Previously Immunized With a Glycoconjugate Vaccine

scientific article published on 01 November 2011

Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial

scientific article published on 30 November 2016

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose

scientific article published on 23 September 2013

Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age.

scientific article

Persistence of immune responses induced by Ebola virus vaccines.

scientific article

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

scientific article published on October 2017

Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months.

scientific article

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations

scientific article published on 3 March 2012

Persistent circulation of vaccine serotypes and serotype replacement after five years of UK infant immunisation with PCV13

scientific article published on 01 March 2020

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

scientific article

Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants

scientific article published in June 2013

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

scientific article

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial

scientific article published on 22 November 2017

Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial

scientific article

Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines

scientific article

Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series

scientific article published on 09 July 2020

Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom

scientific article

Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe

scientific article published on 14 August 2020

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

scientific article published on 01 July 2020

Respiratory syncytial virus seasonality and its implications on prevention strategies.

scientific article published in December 2017

Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial

scientific article

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

scientific article published on 08 December 2020

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

scientific article (publication date: 27 May 2010)

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

scientific article published on 18 November 2020

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

scientific article published on 17 November 2020

Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study

scientific article published on 07 February 2019

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

scientific article published on 20 July 2020

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization

scientific article

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kin

scientific article published in July 2013

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study

scientific article published on 5 June 2008

Sex-dependent immune responses to infant vaccination: an individual participant data meta-analysis of antibody and memory B cells.

scientific article

Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine

scientific article published on 28 December 2011

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

scientific article published in February 2021

Sleeping sickness in brothers in london.

scientific article published on September 2004

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine

scientific article

The Antibody Response Following a Booster With Either a 10- or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early Infancy

scientific article

The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.

scientific article published on 6 April 2013

The beginning of the end for serogroup B meningococcus?

scientific article published on 01 March 2013

The challenge of post-implementation surveillance for novel meningococcal vaccines.

scientific article published on 09 January 2012

The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.

scientific article published in February 2008

The price of prevention: what now for immunisation against meningococcus B?

scientific article published on 01 August 2013

UK vaccination schedule: persistence of immunity to hepatitis B in children vaccinated after perinatal exposure

scientific article published on 9 March 2013

UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence

scientific article published on 28 October 2019

Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers

scientific article published on 16 June 2015

Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing

scientific article published on 24 October 2020

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy.

scientific article published on 28 October 2016

Where next? The emergence of hypervirulent W meningococcus in the Netherlands

scientific article published on 24 August 2017

Will booster doses be required for serogroup B meningococcal vaccine?

scientific article published on 23 January 2014